コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ain or improve the antioxidant properties of capsaicin.
2 cyanate (AITC; also known as mustard oil) or capsaicin.
3 tive following id histamine, chloroquine, or capsaicin.
4 mpared with the prototypical soluble agonist capsaicin.
5 nced the internalisation of nanoencapsulated capsaicin.
6 ting the redox reaction for the detection of capsaicin.
7 to better understand the redox mechanism of capsaicin.
8 arge cells, most of which did not respond to capsaicin.
9 mal similar to that of the aromatic group of capsaicin.
10 let and mechanisms of binding site access by capsaicin.
11 eal a preferred interfacial localization for capsaicin.
12 .3-fold by the addition of the TRPV1 agonist capsaicin.
13 TRPV1 worms exhibit an aversive response to capsaicin.
14 ed by inhalation of the nociceptor stimulant capsaicin.
15 activated by vanilloid compounds, including capsaicin.
16 e, as were the effects of the application of capsaicin.
17 fibres, 70% of which were also activated by capsaicin.
18 d by sweat-triggered ejection of menthol and capsaicin.
19 y responses to intralaryngeal application of capsaicin (10 microg/ml, 50 microl), a selective stimula
20 increasing rheobase, decreasing responses to capsaicin (2 mum) and reducing action potential discharg
21 d samples at different concentration ranges: capsaicin (28.23-2322.35microg/g), vitexin (2.93-33.46mi
22 epper, garlic and mountain pepper, were K(a, capsaicin) = 3.5206 x 10(-16) mol/L, K(a, allicin) = 5.0
23 was expressed in hADSC, and the TRPV1 ligand capsaicin (5uM) stimulated proliferation, which could be
25 ONALE: Heightened cough responses to inhaled capsaicin, a transient receptor potential vanilloid 1 (T
28 e naked mole-rat with the painful substances capsaicin, acid (hydrogen chloride, pH 3.5), and allyl i
30 Noradrenaline or clonidine inhibited the capsaicin-activated current by approximately 60%, and th
33 radrenaline and clonidine were tested on the capsaicin-activated current recorded from acutely dissoc
34 opamine receptor agonists were tested on the capsaicin-activated current recorded from acutely dissoc
35 3, the inhibitory effect of SKF 81297 on the capsaicin-activated current was greatly reduced, suggest
36 he inhibitory effect of noradrenaline on the capsaicin-activated current was greatly reduced, suggest
37 he inhibitory effect of noradrenaline on the capsaicin-activated current was not affected either by b
38 The inhibitory effect of SKF 81297 on the capsaicin-activated current was not affected when the pr
40 e preassociated in resting live cells, while capsaicin activation induced both the formation of more
41 only validate our current working model for capsaicin activation of TRPV1 but also should help guide
44 ults showed that the activation constants by capsaicin, allicin and sanshool, the active components o
45 of mean force (i.e., free energy profile) of capsaicin along the bilayer normal confirms that it pref
50 these questions, we designed a pair of novel capsaicin analogs to increase or decrease the ligand siz
53 AT3 expression and also with the content of capsaicin and dihydrocapsacin during fruit development.
55 and IBS were used in a mixed linear model of capsaicin and dihydrocapsaicin content and fruit weight
56 tem has been tested for the determination of capsaicin and dihydrocapsaicin from fresh chilli and swe
57 ietary fat increased the bioaccessibility of capsaicin and dihydrocapsaicin in digestions with red pe
58 ocessing on the in vitro bioaccessibility of capsaicin and dihydrocapsaicin was studied in the absenc
60 H. armigera, but insignificantly inhibited (capsaicin and gossypol) or induced (nicotine) it in H. a
63 tion in palpebral opening and an increase in capsaicin and menthol-evoked responses only in female mi
65 channel activated by painful stimuli such as capsaicin and noxious heat, and enriched in sensory neur
66 mmation, we stimulated lung nociceptors with capsaicin and observed increased neuropeptide release an
67 linositol lipids occupy the binding site for capsaicin and other vanilloid ligands, suggesting a mech
68 dents, and antinociceptive properties in the capsaicin and partial sciatic nerve ligation models in m
69 essfully introduced high-affinity binding of capsaicin and resiniferatoxin to the vanilloid-insensiti
71 r only to capsaicin (COR neurons) or to both capsaicin and the endogenous TRPV1 and CB1 receptor liga
74 PM8-positive small neurons also responded to capsaicin, and had significantly larger menthol-induced
75 tivated by heat and pungent agents including capsaicin, and has been extensively studied in nocicepti
80 tive primary sensory neurons by burn injury, capsaicin application or sustained electrical activation
82 sensory neuron-derived exosomes released by capsaicin are readily phagocytosed by macrophages in whi
84 tion of TRPV1 abolished all these effects of capsaicin as well as vasoconstriction triggered by lysop
85 ult in increased cough reflex sensitivity to capsaicin associated with an increase in 24-hour spontan
87 nd 30-day cutaneous regeneration after thigh capsaicin axotomy were compared for participants with ty
89 er confirm that Y511, known to be crucial to capsaicin binding, has a distribution along the bilayer
90 s in mice by interacting with the vanilloid (capsaicin)-binding pocket and promoting the stabilizatio
91 onal quantification revealed the location of capsaicin-binding site and critical residues mediating l
93 with COPD had heightened cough responses to capsaicin but reduced responses to prostaglandin E2 comp
94 obility decreased upon channel activation by capsaicin, but only in the presence of extracellular Ca(
101 cacy and potency in preclinical and clinical capsaicin challenge studies; despite this improved pharm
103 on neurones showed no changes in response to capsaicin, cholecystokinin and potassium chloride in TNX
105 of diverse accessions are in agreement with capsaicin content (CA) and fruit weight (FW) classificat
106 of catalase and peroxidase, chlorophyll and capsaicin content gradually decreased for all the treate
108 acologically, neurons respond either only to capsaicin (COR neurons) or to both capsaicin and the end
110 ocomotor adaptation task with pain on Day 1 (capsaicin cream around the ankle), while the task was pe
112 glia, which activated even more neurons than capsaicin, did not produce myenteric activation or contr
114 nornordihydrocapsaicin, nordihydrocapsaicin, capsaicin, dihydrocapsaicin, homocapsaicin and homodihyd
115 he contents of the four major capsaicinoids: capsaicin, dihydrocapsaicin, nordihydrocapsaicin, and ho
116 uscle contractions induced by application of capsaicin, direct colon stimulation, stimulation of ExPA
117 was performed at screening to determine the capsaicin dose inducing a half-maximal response, which w
118 ny concentration of capsaicin (Emax) and the capsaicin dose inducing half-maximal response (ED50).
119 tional analyses in Caenorhabditis elegans As capsaicin elicits heat and pain sensations in mammals, t
120 ough response evoked by any concentration of capsaicin (Emax) and the capsaicin dose inducing half-ma
122 nts with stable asthma exhibited exaggerated capsaicin-evoked cough responses consistent with neurona
124 on awake cough frequency (primary outcome), capsaicin-evoked cough, and patient-reported outcomes.
127 se from hindpaw skin biopsies, and increased capsaicin-evoked inward current and membrane expression
128 TRPV1 activity, as demonstrated by increased capsaicin-evoked nocifensive responses, increased calcit
132 ochemical biosensor for the determination of capsaicin extracted from chilli fruits, based on a novel
137 ptive responses to intraplantar injection of capsaicin, formalin, or complete Freund's adjuvant more
139 gion of India evaluated showed variation for capsaicin from 0.27% (CHF-CA-1) to 3.03% (CHF-CA-21), ol
141 renal nerves, renal afferent disruption with capsaicin had no effect on blood pressure or renal infla
143 oposal as second line for lidocaine patches, capsaicin high-concentration patches, and tramadol; and
145 simulations were used to explore behavior of capsaicin in a 1-palmitoyl-2-oleoyl phosphatidylcholine
146 EN-D0501 and SB-705498 were profiled against capsaicin in a sensory nerve activation assay and in viv
147 highly improved the voltammetric process of capsaicin in comparison to the CNTs/GCE and bare GCE.
148 ic afferents, and sensitization responses to capsaicin in dorsal root ganglia (DRGs) following applic
149 r study comparing cough responses to inhaled capsaicin in patients with mild atopic asthma after alle
151 n of submucosal neurons by the TRPV1 agonist capsaicin in rectal biopsy specimens collected from 9 pa
153 as successfully been applied for quantifying capsaicin in various pepper samples including Isot.
154 orresponded to reduced sensitivity to 100 nM capsaicin in vitro (IC50 = 230 +/- 20 nM, 76 +/- 4.4% wi
155 ntraduodenal capsaicin infusion (1.5 mg pure capsaicin) in healthy volunteers on hunger, satiety, and
157 inal domain features an enhanced response to capsaicin, independent of the phosphoinositide lipid con
159 Investigations of Swiss Albino mice through capsaicin induced paw lickings and dextran induced infla
160 dependent signaling plays a dominant role in capsaicin-induced ablation of nociceptive terminals and
161 Ca(2+) influx through TRPV1 is necessary for capsaicin-induced ablation of nociceptive terminals.
165 plasmic reticulum (ER) Ca(2+) stores reduced capsaicin-induced Ca(2+) increases and CaCC activation,
166 ombinant human TRPV1 channels, 4 antagonized capsaicin-induced Ca(2+) influx, with an IC50 value of 4
168 as none of the mutations selectively altered capsaicin-induced changes in NMDG permeability, the loss
171 old more potent than SB-705498 at inhibiting capsaicin-induced depolarization of guinea pig and human
172 and primary afferent cultures, we monitored capsaicin-induced effects on afferent terminals in real
173 hibited nociceptive transmission by reducing capsaicin-induced internalization of NK-1 and phosphoryl
175 rons from stg/stg mice, but the amplitude of capsaicin-induced mEPSCs from C-fiber synapses was unalt
176 itch in the current-voltage relationships of capsaicin-induced mEPSCs, from linear to inwardly rectif
177 d slices, clonidine reduced the frequency of capsaicin-induced miniature EPSCs in the presence of tet
179 responses in formalin-induced tonic pain, in capsaicin-induced neurogenic pain, and notably in oxalip
180 nduced pruritus (itch) and additionally in a capsaicin-induced nociception model of pain without any
183 compound 30 rescued albino mice by 80% from capsaicin-induced paw licking and recovered it by 60% fr
187 investigate the effects of an intraduodenal capsaicin infusion (1.5 mg pure capsaicin) in healthy vo
188 gallbladder volumes were observed after the capsaicin infusion compared with after the placebo infus
192 f capsaicin-sensitive rat TRPV1 (rTRPV1) and capsaicin-insensitive chicken TRPV1 (cTRPV1) exposed to
194 atory responses evoked by microinjections of capsaicin into the paratrigeminal nucleus were significa
199 w that activation of multiple terminals by a capsaicin-like current allows summation of the responses
203 tantially reduced maximal cough responses to capsaicin (mean change from baseline, XEN-D0501, -19.3 +
205 TLR5-mediated Abeta-fiber blockade, but not capsaicin-mediated C-fiber blockade, also reduced chemot
207 timal ligand-binding pocket conformation for capsaicin-mediated TRPV1 activation gating, and reveals
208 orosensory afferent neurons also respond to capsaicin, menthol, and/or mustard oil (allyl isothiocya
213 itis (IR) is a prevalent condition for which capsaicin nasal spray is the most effective treatment.
215 nd, placebo-controlled randomized trial with capsaicin nasal spray was performed involving 33 patient
216 ture is convincing regarding the efficacy of capsaicin nasal treatment in idiopathic rhinitis (IR).
217 aneous HA injection in mice reduces heat and capsaicin nocifensive responses, whereas the intra-artic
220 st days, an intraduodenal infusion of either capsaicin or a placebo (physiologic saline) was performe
221 estricted to temperature and does not affect capsaicin or acid responses, thereby maintaining a role
223 sponse to intracolonic application of either capsaicin or mustard oil, stimuli known to evoke sustain
224 cals of the tested hostplants significantly (capsaicin) or insignificantly (gossypol and nicotine) in
228 -S4 transmembrane helices in the presence of capsaicin placed in the aqueous phase, in the lipid, or
229 ramers correlates with channel activation by capsaicin, providing an optical marker of conformational
230 vars is highly variable, with the content of capsaicin ranging from 31% to 71% of the total capsaicin
231 he cannabinoid type 1 (CB1) receptor and the capsaicin receptor (TRPV1) exhibit co-expression and com
233 through the activation of the heat-sensitive capsaicin receptor TRPV1 by magnetic nanoparticles.
235 threshold temperature of the heat-sensitive capsaicin receptor TRPV1 ion channel, leading to its act
237 le responses to capsaicin when the mammalian capsaicin receptor VR1 was ectopically expressed in thei
241 arting from the cytosolic aqueous phase, and capsaicin remained stable in the majority of simulations
242 - menthol, allyl isothiocyanate (AITC), and capsaicin, respectively - at concentrations found in foo
243 s elicited by id histamine, chloroquine, and capsaicin, respectively, 3.7%, 4.3%, and 4.1% were retro
245 (IC50 = 230 +/- 20 nM, 76 +/- 4.4% wild-type capsaicin responders vs. 56.9 +/- 4.7% HDAC4 cKO respond
247 tential vanilloid subtype 1 (TRPV1)-mediated capsaicin responses via Toll-like receptor 4 (TLR4) in m
248 d nocifensive responses and sensitization of capsaicin responses were significantly attenuated in the
250 demonstrate that intra-arterial infusion of capsaicin results in a dose-related rise in MAP and HR t
251 rase inhibitor huprine Y and the antioxidant capsaicin results in compounds with nanomolar potencies
252 nsory nerves did not affect the responses to capsaicin revealing a vascular smooth muscle-restricted
253 f proline-rich protein and mucin 7 following capsaicin (rho = 0.71, p = 0.02, rho = 0.68, p = 0.04, r
254 ce, there was an increase in the fraction of capsaicin-sensitive cells relative to wild type (WT) con
256 show that GRP directly activates small-size capsaicin-sensitive DRG neurons, an effect that translat
257 imaging to characterize chimeras composed of capsaicin-sensitive rat TRPV1 (rTRPV1) and capsaicin-ins
258 residues responsible for differential TRPV1 capsaicin sensitivity among species, we used intracellul
261 686 swapped into chicken receptors displayed capsaicin sensitivity, and that simply changing the alan
262 erone did not activate any A578 mutants with capsaicin sensitivity, suggesting that the vanilloid gro
267 er, interactions were seen between TRPV1 and capsaicin starting from the cytosolic aqueous phase, and
268 tidergic CGRP/somatostatin+ nociceptors upon capsaicin stimulation exert a tonic inhibitory control o
269 e Fos-positive neurons following pruritic or capsaicin stimuli, approximately 1-2% were retrogradely
270 Oral administration of the TRPV1 agonist, capsaicin, suppressed ligature-induced bone loss in mice
272 acids are better tolerated for activation by capsaicin than for activation by hot temperature, sugges
273 ecent studies have shown a metabolic role of capsaicin that may be mediated via the transient recepto
274 d in pain sensation, and is the receptor for capsaicin, the active ingredient of hot chili peppers.
275 The best known agonist of TRPV1 channels is capsaicin, the pungent component of "hot" chili peppers.
279 des, is demonstrated in the determination of capsaicin through adsorptive stripping voltammetry.
280 e is relatively unstable, whereas binding of capsaicin to TRPV2_Quad antagonizes resiniferatoxin-indu
283 showed a trend to being better responders to capsaicin treatment compared with patients with IR but w
284 patients with IR and symptom reduction after capsaicin treatment demonstrates the clinical relevance
286 s and the increased threshold for AITC after capsaicin treatment in patients with IR demonstrate the
288 However, the functional consequences of capsaicin treatment on nasal nerve activation and the as
291 rans-tympanic (TT) or oral administration of capsaicin (TRPV1 agonist) prevents cisplatin ototoxicity
295 utants and WT showed comparable responses to capsaicin when the mammalian capsaicin receptor VR1 was
296 itide lipids display an enhanced response to capsaicin, whereas phosphoinositide lipid supplementatio
297 al rhizotomy nor an intrathecal injection of capsaicin, which completely eliminated spinal cord TRPV1
300 rdic response to intralaryngeal perfusion of capsaicin, which was associated with up-regulation of TR